INVYMAB
Live / Registered — Registered (as of 18 Nov 2025)
What this means for you
Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Nov 2031: the §8 declaration of use).
Record
- Serial number
- 98196192
- Registration number
- 8033550
- Mark type
- Word mark
- Filed
- 25 Sept 2023
- Published for opposition
- 25 Jun 2024
- Registered
- 18 Nov 2025
- Next maintenance filing
- §8 declaration of use, due by 18 Nov 2031 (grace period to 18 May 2032)
- Attorney of record
- James J. Saul
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development relating to pharmaceutical preparations and substances for the treatment and prevention of infectious diseases; providing medical and scientific research information in the field of pharmaceuticals for the treatment and prevention of infectious diseases
Owner
- Invivyd, Inc., New Haven, CT, US
- Invivyd, Inc., Waltham, MA, US
- Invivyd, Inc., Waltham, MA, US
Prosecution history
- 30 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 27 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 13 May 2025 — USE AMENDMENT FILED
- 16 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 1 GRANTED